Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10201/49448
Twittear
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Jung, C.S. | - |
dc.contributor.author | Unterberg, A.W. | - |
dc.contributor.author | Hartmann, C. | - |
dc.date.accessioned | 2016-04-29T17:04:42Z | - |
dc.date.available | 2016-04-29T17:04:42Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1699-5848 | - |
dc.identifier.issn | 0213-3911 | - |
dc.identifier.uri | http://hdl.handle.net/10201/49448 | - |
dc.description.abstract | Glioblastoma (GBM) is the most malignant form of cerebral gliomas, and despite distinct progress in surgical resection, radiation and chemotherapy, the prognosis of patients with GBM is still very poor. In the past decades knowledge of genomics and proteomics and of diagnostic, prognostic, predictive and pharmakodynamic markers measured in cerebrospinal-fluid (CSF), serum, or tumor tissue biomarkers has improved. This review briefly compiles our concepts on diagnostic markers for GBM, focusing on the latest developments. | es |
dc.format | application/pdf | es |
dc.format.extent | 15 | es |
dc.language | eng | es |
dc.publisher | F. Hernández y J.F. Madrid. Murcia: Universidad de Murcia, Departamento de Biología Celular e Histología. | es |
dc.relation.ispartof | Histology and histopathology, Vol. 26, nº10 (2011) | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.subject | Glioblastoma | es |
dc.subject | Biomarkers | es |
dc.subject.other | 616 - Patología. Medicina clínica. Oncología | es |
dc.title | Diagnostic markers for glioblastoma | es |
dc.type | info:eu-repo/semantics/article | es |
Aparece en las colecciones: | Vol.26,nº10 (2011) |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Jung-26-1327-1341-2011.pdf | 581,86 kB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons